Khosla Ventures (KVSA) Adds to Valo Health PIPE
Khosla Ventures Acquisition Co. (NASDAQ:KVSA) announced this afternoon that it has added another $1.125 million to the PIPE for its deal with drug discovery platform Valo Health. The recent commitments were made by Valo’s CEO & Founder David Berry, and CFO Graeme Bell, which will be subject to a 180-day lock-up following the closing. TheRead More